Next Article in Journal
Women’s Views about Breast Cancer Prevention at Mammography Screening Units and Well Women’s Clinics
Previous Article in Journal
Consensus Statement on Tumour Bed Localization for Radiation after Oncoplastic Breast Surgery
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 27
Issue 3
10.3747/co.27.6769
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Management of Chronic Lymphocytic Leukemia in Canada during the Coronavirus Pandemic

by
L.H. Sehn
1,2,*,
P. Kuruvilla
3,
A. Christofides
4 and
J. Stakiw
5
1
BC Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada
2
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
3
William Osler Health System, Brampton Civic Hospital, Brampton, ON, Canada
4
impact Medicom Inc., Toronto, ON, Canada
5
Saskatoon Cancer Centre, Saskatchewan Cancer Agency, Saskatoon, SK, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2020, 27(3), 332-335; https://doi.org/10.3747/co.27.6769
Submission received: 3 March 2020 / Revised: 5 April 2020 / Accepted: 7 May 2020 / Published: 1 June 2020

Abstract

The emergence of the covid-19 disease pandemic caused by the 2019 novel coronavirus has required a re-evaluation of treatment practices for clinicians caring for patients with chronic lymphocytic leukemia (cll). The American Society for Hematology (ash) has provided a series of recommendations for the treatment of patients with cll during the pandemic, covering a range of topics, including testing for covid-19, cll treatment initiation and selection, use of immunoglobulin therapy, in-person monitoring, and treatment of patients with cll and covid-19. We summarize the ash recommendations and discuss their applicability as guidelines for the treatment of cll during the covid-19 pandemic in Canada.
Keywords: coronavirus; covid-19; chronic lymphocytic leukemia coronavirus; covid-19; chronic lymphocytic leukemia

Share and Cite

MDPI and ACS Style

Sehn, L.H.; Kuruvilla, P.; Christofides, A.; Stakiw, J. Management of Chronic Lymphocytic Leukemia in Canada during the Coronavirus Pandemic. Curr. Oncol. 2020, 27, 332-335. https://doi.org/10.3747/co.27.6769

AMA Style

Sehn LH, Kuruvilla P, Christofides A, Stakiw J. Management of Chronic Lymphocytic Leukemia in Canada during the Coronavirus Pandemic. Current Oncology. 2020; 27(3):332-335. https://doi.org/10.3747/co.27.6769

Chicago/Turabian Style

Sehn, L.H., P. Kuruvilla, A. Christofides, and J. Stakiw. 2020. "Management of Chronic Lymphocytic Leukemia in Canada during the Coronavirus Pandemic" Current Oncology 27, no. 3: 332-335. https://doi.org/10.3747/co.27.6769

APA Style

Sehn, L. H., Kuruvilla, P., Christofides, A., & Stakiw, J. (2020). Management of Chronic Lymphocytic Leukemia in Canada during the Coronavirus Pandemic. Current Oncology, 27(3), 332-335. https://doi.org/10.3747/co.27.6769

Article Metrics

Back to TopTop